NCT06800469 Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer
| NCT ID | NCT06800469 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Pancreatic Cancer, Adult |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2022-07-11 |
| Primary Completion | 2025-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2022-07-11 with a primary completion date of 2025-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Pancreatic head cancer represents one of the most frequent malignancies with an incidence of about 13500 new cases each year. The primary objective of the study is to test whether there are bacterial species associated with increased risk of complications in patients with peri-ampullary neoplasia undergoing DCP.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years * Diagnosis of resectable pancreatic adenocarcinoma with indication for "upfront" surgical treatment * ASA (American Society of Anesthesiology) score \< 4 * Obtaining informed consent Exclusion Criteria: \- Pregnant or lactating women
Contact & Investigator
Ricci Claudio, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06800469 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreatic Cancer, Adult. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06800469 currently recruiting?
Yes, NCT06800469 is actively recruiting participants. Contact the research team at claudio.ricci@aosp.bo.it for enrollment information.
Where is the NCT06800469 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06800469 clinical trial?
NCT06800469 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Ricci Claudio, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.